ArticleFundamental research2023
Artificial intelligence reinforced upconversion nanoparticle-based lateral flow assay via transfer learning.
Article in Fundamental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Evolution of Next-Generation Multiplex Lateral Flow Immunoassays: From Engineered Nanomaterials to AI-Driven Detection.Biosensors · 2026Review
- Emerging Trends in Artificial Intelligence-Assisted Colorimetric Biosensors for Pathogen Diagnostics.Sensors (Basel, Switzerland) · 2026Review
- Research Progress on the Application of Upconversion Nanoparticles in Heavy Metal Detection in Foodstuff.Foods (Basel, Switzerland) · 2025Review
- Deep Learning-Driven Intelligent Fluorescent Probes: Advancements in Molecular Design for Accurate Food Safety Detection.Foods (Basel, Switzerland) · 2025Review
- Advancements and Applications of Lateral Flow Assays (LFAs): A Comprehensive Review.Sensors (Basel, Switzerland) · 2025Review
- The Role of Artificial Intelligence in Advancing Biosensor Technology: Past, Present, and Future Perspectives.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Smartphone-Powered Automated Image Recognition Tool for Multianalyte Rapid Tests: Application to Infectious Diseases.Analytical chemistry · 2025Article
- Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics.Nature communications · 2025Article
- Machine learning in point-of-care testing: innovations, challenges, and opportunities.Nature communications · 2025Review
- Impact of nanotechnology on conventional and artificial intelligence-based biosensing strategies for the detection of viruses.Discover nano · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The combination of upconverting nanoparticles (UCNPs) and immunochromatography has become a widely used and promising new detection technique for point-of-care testing (POCT). However, their low luminescence efficiency, non-specific adsorption, and image noise have always limited their progress toward practical applications. Recently, artificial intelligence (AI) has demonstrated powerful representational learning and generalization capabilities in computer vision. We report for the first time a combination of AI and upconversion nanoparticle-based lateral flow assays (UCNP-LFAs) for the quantitative detection of commercial internet of things (IoT) devices. This universal UCNPs quantitative detection strategy combines high accuracy, sensitivity, and applicability in the field detection environment. By using transfer learning to train AI models in a small self-built database, we not only significantly improved the accuracy and robustness of quantitative detection, but also efficiently solved the actual problems of data scarcity and low computing power of POCT equipment. Then, the trained AI model was deployed in IoT devices, whereby the detection process does not require detailed data preprocessing to achieve real-time inference of quantitative results. We validated the quantitative detection of two detectors using eight transfer learning models on a small dataset. The AI quickly provided ultra-high accuracy prediction results (some models could reach 100% accuracy) even when strong noise was added. Simultaneously, the high flexibility of this strategy promises to be a general quantitative detection method for optical biosensors. We believe that this strategy and device have a scientific significance in revolutionizing the existing POCT technology landscape and providing excellent commercial value in the in vitro diagnostics (IVD) industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.